Literature DB >> 25356363

Enteroaggregative Shiga toxin-producing Escherichia coli of serotype O104:H4 in Belgium and Luxembourg.

K De Rauw1, S Vincken2, L Garabedian3, E Levtchenko3, I Hubloue4, J Verhaegen5, J Craeghs6, Y Glupczynski7, J Mossong8, D Piérard1.   

Abstract

In 2011, a large outbreak of infections caused by Shiga toxin-producing Escherichia coli (STEC) O104:H4 occurred in Germany. This exceptionally virulent strain combined virulence factors of enteroaggregative E. coli (EAggEC) and STEC. After the outbreak only a few sporadic cases of infection with this rare serotype were reported, most of which were related to travel to the Middle East or North Africa. Here we describe two cases of enteroaggregative STEC (Agg-STEC) O104:H4 infection that occurred in Belgium in 2012 and 2013 respectively. In both cases travel in a Mediterranean country preceded the infection. The first strain was isolated from the stool of a 42-year-old woman presenting bloody diarrhoea, who had travelled to Tunisia the week before. The second case involves a 14-year-old girl who, upon her return from Turkey to Belgium, suffered from an episode of bloody diarrhoea and haemolytic uraemic syndrome. Extended typing of the isolates with pulsed field gel electrophoresis revealed that the strains were closely related, though not exactly the same as the 2011 outbreak strain. This report supports the previously made hypothesis that Agg-STEC has a human reservoir and might be imported by travellers coming from an area where the pathogen is endemic. Furthermore, it emphasizes the concern that these bacteria may cause future outbreaks as evenly virulent O104:H4 isolates seem to be widespread.

Entities:  

Keywords:  Enteroaggregative Escherichia coli; Shiga toxin-producing E. coli; enterohaemorrhagic E. coli; gastrointestinal disease; haemolytic uraemic syndrome; travel

Year:  2014        PMID: 25356363      PMCID: PMC4184478          DOI: 10.1002/nmi2.58

Source DB:  PubMed          Journal:  New Microbes New Infect        ISSN: 2052-2975


  28 in total

1.  Outbreak of haemolytic uraemic syndrome due to Shiga toxin-producing Escherichia coli O104:H4 among French tourists returning from Turkey, September 2011.

Authors:  N Jourdan-da Silva; M Watrin; F X Weill; L A King; M Gouali; A Mailles; D van Cauteren; M Bataille; S Guettier; C Castrale; P Henry; P Mariani; V Vaillant; H de Valk
Journal:  Euro Surveill       Date:  2012-01-26

2.  Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011.

Authors:  F Scheutz; E Møller Nielsen; J Frimodt-Møller; N Boisen; S Morabito; R Tozzoli; J P Nataro; A Caprioli
Journal:  Euro Surveill       Date:  2011-06-16

3.  Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature.

Authors:  Flemming Scheutz; Louise D Teel; Lothar Beutin; Denis Piérard; Glenn Buvens; Helge Karch; Alexander Mellmann; Alfredo Caprioli; Rosangela Tozzoli; Stefano Morabito; Nancy A Strockbine; Angela R Melton-Celsa; Maria Sanchez; Søren Persson; Alison D O'Brien
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

4.  Genotypes and virulence characteristics of Shiga toxin-producing Escherichia coli O104 strains from different origins and sources.

Authors:  Angelika Miko; Sabine Delannoy; Patrick Fach; Nancy A Strockbine; Björn Arne Lindstedt; Patricia Mariani-Kurkdjian; Jochen Reetz; Lothar Beutin
Journal:  Int J Med Microbiol       Date:  2013-05-28       Impact factor: 3.473

5.  Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology.

Authors:  Alexander Mellmann; Dag Harmsen; Craig A Cummings; Emily B Zentz; Shana R Leopold; Alain Rico; Karola Prior; Rafael Szczepanowski; Yongmei Ji; Wenlan Zhang; Stephen F McLaughlin; John K Henkhaus; Benjamin Leopold; Martina Bielaszewska; Rita Prager; Pius M Brzoska; Richard L Moore; Simone Guenther; Jonathan M Rothberg; Helge Karch
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

6.  Similarity of Shiga toxin-producing Escherichia coli O104:H4 strains from Italy and Germany.

Authors:  Gaia Scavia; Stefano Morabito; Rosangela Tozzoli; Valeria Michelacci; Maria Luisa Marziano; Fabio Minelli; Clarissa Ferreri; Fabio Paglialonga; Alberto Edefonti; Alfredo Caprioli
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

7.  Escherichia coli O104:H4 from 2011 European outbreak and strain from South Korea.

Authors:  Junyoung Kim; Kyunghwan Oh; Semi Jeon; Seonghak Cho; Deogyong Lee; Sahyun Hong; Seongbeom Cho; Misun Park; Dooyoung Jeon; Seonghan Kim
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

8.  Comparative genomics of recent Shiga toxin-producing Escherichia coli O104:H4: short-term evolution of an emerging pathogen.

Authors:  Yonatan H Grad; Paul Godfrey; Gustavo C Cerquiera; Patricia Mariani-Kurkdjian; Malika Gouali; Edouard Bingen; Terrence P Shea; Brian J Haas; Allison Griggs; Sarah Young; Qiandong Zeng; Marc Lipsitch; Matthew K Waldor; François-Xavier Weill; Jennifer R Wortman; William P Hanage
Journal:  MBio       Date:  2013-01-22       Impact factor: 7.867

9.  Adaptive mutations and replacements of virulence traits in the Escherichia coli O104:H4 outbreak population.

Authors:  Lionel Guy; Cecilia Jernberg; Jenny Arvén Norling; Sofie Ivarsson; Ingela Hedenström; Öjar Melefors; Ulrika Liljedahl; Lars Engstrand; Siv G E Andersson
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

Review 10.  O157:H7 and O104:H4 Vero/Shiga toxin-producing Escherichia coli outbreaks: respective role of cattle and humans.

Authors:  Denis Piérard; Henri De Greve; Freddy Haesebrouck; Jacques Mainil
Journal:  Vet Res       Date:  2012-02-13       Impact factor: 3.683

View more
  7 in total

1.  Detection of Shiga toxin-producing and other diarrheagenic Escherichia coli by the BioFire FilmArray® Gastrointestinal Panel in human fecal samples.

Authors:  K De Rauw; L Detemmerman; J Breynaert; D Piérard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-03       Impact factor: 3.267

2.  Comparative genomic analysis of two novel sporadic Shiga toxin-producing Escherichia coli O104:H4 strains isolated 2011 in Germany.

Authors:  Erhard Tietze; Piotr Wojciech Dabrowski; Rita Prager; Aleksandar Radonic; Angelika Fruth; Philipp Auraß; Andreas Nitsche; Martin Mielke; Antje Flieger
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

3.  Comprehensive Characterization of Escherichia coli O104:H4 Isolated from Patients in the Netherlands.

Authors:  Mithila Ferdous; Kai Zhou; Richard F de Boer; Alexander W Friedrich; Anna M D Kooistra-Smid; John W A Rossen
Journal:  Front Microbiol       Date:  2015-12-02       Impact factor: 5.640

4.  Human Campylobacteriosis in Luxembourg, 2010-2013: A Case-Control Study Combined with Multilocus Sequence Typing for Source Attribution and Risk Factor Analysis.

Authors:  Joël Mossong; Lapo Mughini-Gras; Christian Penny; Anthony Devaux; Christophe Olinger; Serge Losch; Henry-Michel Cauchie; Wilfrid van Pelt; Catherine Ragimbeau
Journal:  Sci Rep       Date:  2016-02-10       Impact factor: 4.379

5.  Haemolytic uremic syndrome surveillance in children less than 15 years in Belgium, 2009-2015.

Authors:  S Jacquinet; K De Rauw; D Pierard; N Godefroid; L Collard; K Van Hoeck; M Sabbe
Journal:  Arch Public Health       Date:  2018-08-06

6.  Diarrheagenic Escherichia Coli O157 from Libya: Recent Perspectives and Challenges.

Authors:  Mohamed O Ahmed; Nariman F Almshawt; Hiam R Elnageh
Journal:  J Public Health Afr       Date:  2017-09-04

7.  Twenty-seven years of screening for Shiga toxin-producing Escherichia coli in a university hospital. Brussels, Belgium, 1987-2014.

Authors:  Klara De Rauw; Steve Jacobs; Denis Piérard
Journal:  PLoS One       Date:  2018-07-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.